Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Moringa leaf powder is a nutrient-dense dietary supplement derived from the dried and ground leaves of the *Moringa oleifera* tree, often referred to as the "miracle tree." It is characterized by high concentrations of essential vitamins (A, C, and E), minerals (calcium, iron, and potassium), and bioactive phytochemicals, including polyphenols, flavonoids, and isothiocyanates such as moringin. The powder exhibits significant antioxidant activity by scavenging reactive oxygen species and upregulating endogenous antioxidant enzymes. Its anti-inflammatory mechanism involves the suppression of NF-κB signaling, leading to reduced production of pro-inflammatory cytokines like TNF-α and IL-6. Furthermore, moringa leaf powder has been studied for its anti-hyperglycemic effects, which are attributed to the inhibition of alpha-glucosidase and alpha-amylase, as well as the enhancement of insulin secretion and sensitivity. It is widely used in global health initiatives to combat malnutrition and is increasingly researched for its potential in managing metabolic syndrome, including type 2 diabetes and dyslipidemia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on moringa leaf powder.